October - 2024

top of page

Subscribe to our newsletter

News

Categories

Sign up

Featured Posts

How Israeli technology saved 78-year-old Leah from skin cancer

How Israeli technology saved 78-year-old Leah from skin cancer

How Israeli technology saved 78-year-old Leah from skin cancer

Alpha-emitting Radiation Therapy Could Create a Paradigm Shift in Cancer Treatment

Alpha-emitting Radiation Therapy Could Create a Paradigm Shift in Cancer Treatment

Alpha-emitting Radiation Therapy Could Create a Paradigm Shift in Cancer Treatment

Alpha DaRT treatment proves a success in first-in-human trial

Alpha DaRT treatment proves a success in first-in-human trial

Alpha DaRT treatment proves a success in first-in-human trial

Israel's alpha radiation treatment shows tumor shrinkage in 100% of cases

Israel's alpha radiation treatment shows tumor shrinkage in 100% of cases

Israel's alpha radiation treatment shows tumor shrinkage in 100% of cases

Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha Ra

Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha Ra

Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha Ra

Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure Cancer

Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure Cancer

Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure Cancer

Alpha Tau’s High-Precision Cancer Radiotherapy Receives Radioactive-Safety Approval in the United St

Alpha Tau’s High-Precision Cancer Radiotherapy Receives Radioactive-Safety Approval in the United St

Alpha Tau’s High-Precision Cancer Radiotherapy Receives Radioactive-Safety Approval in the United St

First Alpha Tau Medical Summit Gathers Over 200 Oncologists and Physicians From all Around the World

First Alpha Tau Medical Summit Gathers Over 200 Oncologists and Physicians From all Around the World

First Alpha Tau Medical Summit Gathers Over 200 Oncologists and Physicians From all Around the World

Archive

Follow Us

Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme

Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme

Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme

JERUSALEM, October 21, 2024 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...

Oct 21, 2024

Alpha Tau Treats First Patient with Recurrent Lung Cancer

Alpha Tau Treats First Patient with Recurrent Lung Cancer

Alpha Tau Treats First Patient with Recurrent Lung Cancer

first patient with recurrent lung cancer has been treated, in a clinical trial at Hadassah Medical Center in Jerusalem, Israel.

Oct 10, 2024

bottom of page